NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls - Russell‐Goldman - 2018 - Cancer Cytopathology - Wiley Online Library
Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma
Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma | Modern Pathology
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients - eBioMedicine
ProGRP is a possible tumor marker for patients with Ewing sarcoma. | Semantic Scholar
Pathobiologic Markers of the Ewing Sarcoma Family of Tumors: State of the Art and Prediction of Behaviour